Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study

By Penna I.A.A.  

Human Reproduction, Vol. 20, Iss. 9, 2005-09 ,pp. : 2396-2401

Oxford University Press

Access to resources Recommend Favorite

Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial

By Trolle B.   Flyvbjerg A.   Kesmodel U.   Lauszus F.F.  

Human Reproduction, Vol. 22, Iss. 11, 2007-11 ,pp. : 2967-2973

Oxford University Press

Access to resources Recommend Favorite

Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial

By Fux Otta CarolinaFux   Wior Myriam   Iraci Gabriel S.   Kaplan Raquel   Torres Diana   Gaido María Isabel   Wyse Eduardo P.  

Gynecological Endocrinology, Vol. 26, Iss. 3, 2010-03 ,pp. : 173-178

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome

By Nyhlin H.   Bang C.   Elsborg L.   Silvennoinen J.   Holme I.   Rüegg P.   Jones J.   Wagner A.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 119-126

Informa Healthcare

Access to resources Recommend Favorite

Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study

By Hanjalic-Beck Aida   Gabriel Boris   Schaefer Wolfgang   Zahradnik Hans-Peter   Schories Marcus   Tempfer Clemens   Keck Christoph   Denschlag Dominik  

Gynecological Endocrinology, Vol. 26, Iss. 9, 2010-09 ,pp. : 690-697

Informa Healthcare

Access to resources Recommend Favorite